Sanjeev Thohan

Sanjeev Thohan serves as the Chief Scientific Officer at LatentSpace Therapeutics since July 2024 and has been the Founder of SARx Consulting since January 2009, specializing in nonclinical activities related to small molecules and preclinical toxicology. Sanjeev is also a Scientific Advisory Board Member at both Phoenix Molecular Designs and Cogentis Therapeutics, contributing to innovative cancer therapies and neurotechnology challenges, respectively. Additionally, Sanjeev has held various leadership roles in nonclinical development at Kinnate Biopharma and Xeris Pharmaceuticals, and in toxicology at Novartis. Sanjeev's educational background includes a PhD in Pharmacology and Toxicology from the University of Maryland Baltimore, an MS from the University of Arizona, and a BS from Towson University.